November 18th 2024
AHA 2024. Findings from the BPROAD trial help fill a gap left by similar studies on the ideal target SBP for adults with type 2 diabetes, said study authors.
November 15th 2024
Aprocitentan is the first-and-only dual endothelin receptor antagonist approved for the treatment of systemic hypertension.
September 27th 2024
Your daily dose of the clinical news you may have missed.
September 25th 2024
September 17th 2024
New data shows that favorable CV health in the first trimester is associated with a 35% to 62% lower risk of HDP regardless of level of genetic risk.
Study Shows Benefits of Bariatric Surgery for Mild-to-Moderate Obesity
A new study challenges traditional criteria for patient selection for metabolic surgery, demonstrating significant weight loss and disease remission for those with BMI of 30-35.
Glycemic, BP, Lipid Control in T2D Declining, Upping Risk for Related Disease, Complications
Analysis of NHANES data shows significant downturns in control of the 3 risk factors in patients with diabetes, which could mean population-level increases in related illness.
Counsel Patients on "One Pill Can Kill" Meds in Common Pill Organizers
A new study reveals that nearly three-quarters of medication organizer packages contain a drug class from which a single pill could be lethal for a child.
SPRINT Trial Results Confirmed in New Analysis: Yes, Lower is Better
An analysis of final data from the landmark SPRINT trial has confirmed findings that support aggressive treatment of hypertension to reduce CV morbidity and mortality.
Black Women at Risk Early in Life for Future Cardiovascular Disease
ACC.21: High rates of obesity, hypertension, and hyperlipidemia found in Black women in their 20s and 30s are of significant concern, says the author of a study to be presented at the ACC meeting.
T2D Complications Associated with Objective Measure of Poor Medication Adherence
Robust analyses of urine metabolites detects poor adherence with prescribed treatment in T2D and is associated with prevalence of micro- and macrovascular complications.
These Two Words Could Change Obesity Treatment, says Harold Bays, MD
Long time cardiometabolic investigator Harold Bays, MD, talks about obesity, new drugs to treat the disease, and how the words "be inefficient" could change thinking about treatment.
Meeting Minimum Exercise Guidelines Not Sufficient to Reduce Risk of Hypertension Later in Life
Results of a new study show that young adults who exercise up to 5 hours per week have a reduced risk of developing hypertension later in life.
Functional Assessment Strengthens Red Meat-Heart Disease Association
Measures of heart function and anatomy were used to assess the effects of red and processed meat on cardiovascular health; findings were reported at ESC Preventive Cardiology 2021.
SBP Time in Target Range Associated with Decrease in CV Risk, Study Finds
Post-hoc analysis of the SPRINT trial found greater time spent with systolic blood pressure in target range was significantly associated with decreased risk of MACE.
Black Adults Avoid Hypertension, Reduce CVD Risk with Sustained Lifestyle Habits
Jackson Heart Study participants who maintained a healthy BP, BMI, and never smoked were at lower risk for incident CVD, suggesting targets for intervention in high-risk populations.
New Consensus Document Highlights Which Exercises are Best to Lower Blood Pressure
The new consensus document is the first to offer personalized advice on the most effective exercises to lower blood pressure based on a patient's current blood pressure level.
Study: Two-thirds of COVID-19 Hospitalizations Attributable to 4 Major Cardiometabolic Conditions
A new modeling study estimates that 64% of US COVID-19 hospitalizations were attributable to at least 1 of 4 pre-existing cardiometabolic conditions.
AHA 2021 Statistical Update: Pandemic Impact on CVD Will Be "Exponential"
Heart disease, again the leading cause of death worldwide, may remain so for many years as a result of COVID-19 pandemic conditions, says AHA Update Writing Committee Chair.
Exercise Insufficient to Overcome CVD Risks of Overweight/Obesity
Physical activity cannot compensate adequately for the negative impact of excess body weight on cardiometabolic health.
Black Patients Less Likely to Receive Treatment Intensification for BP Control
AHA 2020 Virtual Scientific Sessions: Nearly one-third of racial disparities in hypertension treatment may be linked to inequities in treatment intensification, study authors suggest.
PREVIEW of AHA 2020 Scientific Sessions: Late-breaking Science, Days 4 and 5
Preview days 4 and 5 of the American Heart Association 2020 live late-breaking science sessions. Decide what you need to watch and when.
AHA 2020 Scientific Sessions Preview: Late-breaking Science, Days 1, 2 and 3
What to watch during the AHA 2020 late-breaking science sessions? We break down the first 3 days of clinical trial presentations for you, here.
Pharmacotherapy for Obesity Should Begin in Primary Care
Video: Obesity expert Dr Louis Aronne outlines the role of medication in obesity treatment and says primary care is absolutely the place to begin.
CLINICAL FOCUS COLLECTION: Preventive Cardiology
Preventive Cardiology Collection Table of Contents: Expert video interviews, short, clinical guideline-focused quizzes, facts at-a-glance slideshows, plus news.
Guideline-directed Weight Loss: 4 Questions for Primary Care Physicians
Rapidly rising obesity rates in the US threaten to reverse decades of effort against cardiometabolic disease. How well do you know what experts recommend for your at-risk patients?
Checklist for Accurate Office BP Measurement
Office blood pressure measurement technique is relatively simple yet widely prone to error. Check your office procedure against guideline recommendations.
Pandemic Makes Remote BP Monitoring Essential
COVID-19 has been a boon for 1 chronic disease: hypertension. Brigham and Women's hypertension expert Dr Naomi Fisher says home BP monitoring programs are expanding, at last.
Blood Pressure Control among US Adults Decreased 11% in Recent Years
New research presented at AHA Hypertension 2020 suggest uncontrolled hypertension is becoming more common among US adults.
Study: Automated Office Blood Pressure Monitoring Not Optimal Way to Determine New Hypertension Diagnosis
AHA Hypertension 2020: New research suggests using automated office blood pressure monitoring is not the ideal way to determine a hypertension diagnosis.
Primary Care Centers Use Outdated Hypertension Diagnostics
AHA Hypertension 2020: Primary care practitioners rely on officed-based BP measures and outdated cut points to diagnose new hypertension.
Moderate Alcohol Consumption Tied to Hypertension Risk in Diabetes
A new research article found moderate and heavy alcohol intake were associated with hypertension in patients with type 2 diabetes.
Visit-to-Visit Variability in BP Associated with Dementia, Cognitive Decline
"Beyond hypertension, higher BPV is a major clinical predictor of cognitive impairment and dementia," conclude authors of a new study.
Telemonitoring May Reduce Heart Attack, Stroke Rate by 50% in Patients with Hypertension
A new study found adults with high blood pressure were about half as likely to have serious cardiovascular events after receiving telemonitoring vs those receiving primary care.
5 Questions on How to Manage Hypertension in Primary Care
Hypertension is the modifiable cardiovascular disease risk factor responsible for the greatest mortality. Test what you know about management.